Document Detail

Regional cerebral blood flow in patients with sickle cell disease: study with single photon emission computed tomography.
MedLine Citation:
PMID:  17952552     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Neurological complications have been reported in patients with sickle-cell disease (SCD) using positron emission tomography (PET), magnetic resonance imaging (MRI), and computed tomography (CT), but not with single photon emission computed tomography (SPECT). The objective of this study was to investigate brain perfusion in the patients with SCD using SPECT after technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO), was administered and compare the findings with those of demography, physical examination, MRI and hematological profile. METHODS: The study involved 21 patients (12 males, 9 females, age at study 8-45 years) who were known to be having SCD for a duration of at least 5 years. The patients were not in acute crisis and had normal neurological assessments with no known history of stroke or transient ischemic episode or previous abnormal CT or MRI brain scan, and were right-handed. The brain SPECT was performed after intravenous injection of 740 MBq (20 mCi) 99mTc-HMPAO in adults or an appropriate dose in pediatric patients. The scans were visually interpreted by two nuclear medicine physicians and a decision was reached by consensus. An MRI done 3 months later was interpreted by a radiologist. The demographic data and hematological profile were obtained from the medical records of the patients. RESULTS: Of the 21 patients, 7 (age 11-22 years) had brain perfusion deficit mostly in the frontal lobe either alone or in combination with temporal and/or parietal lobe. The MRI was abnormal in 2 patients. The brain perfusion deficit was not associated with the demographic data of the patients or hematological profiles. CONCLUSIONS: The findings show that SPECT was useful in detecting brain perfusion deficit in SCD patients, and such an early detection may be clinically useful in the subsequent follow-up of such patients, since it is known that cerebral perfusion deficit can lead to silent infarct and/or overt stroke, and affect cognitive skills.
Fareeda A Al-Kandari; Azu Owunwanne; Ghulam M Syed; Rajaa Ar Marouf; Abdelhamid H Elgazzar; Mehraj Shiekh; Ali M Rizui; Jawaher A Al-Ajmi; Ahmed M Mohammed
Publication Detail:
Type:  Journal Article     Date:  2007-10-25
Journal Detail:
Title:  Annals of nuclear medicine     Volume:  21     ISSN:  0914-7187     ISO Abbreviation:  Ann Nucl Med     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-10-22     Completed Date:  2008-01-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8913398     Medline TA:  Ann Nucl Med     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  439-45     Citation Subset:  IM    
Department of Nuclear Medicine, Faculty of Medicine, Health Sciences Center, Kuwait University, and Mubarak Al-Kabeer Hospital, Saafat, 13110, Kuwait.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia, Sickle Cell / complications*,  radionuclide imaging*
Brain / blood supply*,  radionuclide imaging*
Cerebrovascular Circulation
Cerebrovascular Disorders / etiology*,  radionuclide imaging*
Middle Aged
Radiopharmaceuticals / diagnostic use
Technetium Tc 99m Exametazime / diagnostic use*
Tomography, Emission-Computed, Single-Photon / methods
Reg. No./Substance:
0/Radiopharmaceuticals; 100504-35-6/Technetium Tc 99m Exametazime

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Predictive value of bone marrow accumulation of Tc-99m tetrofosmin for subsequent development of dis...
Next Document:  Stimulation of adenosine A1 receptors decreases in vivo dopamine D1 receptor binding of [11C]SCH2339...